Host control of human papillomavirus infection and disease
- PMID: 28919159
- DOI: 10.1016/j.bpobgyn.2017.08.001
Host control of human papillomavirus infection and disease
Abstract
Most human papillomaviruses cause inapparent infections, subtly affecting epithelial homeostasis, to ensure genome persistence in the epithelial basal layer. As with conspicuous papillomas, these self-limiting lesions shed viral particles to ensure population level maintenance and depend on a balance between viral gene expression, immune cell stimulation and immune surveillance for persistence. The complex immune evasion strategies, characteristic of high-risk HPV types, also allow the deregulated viral gene expression that underlies neoplasia. Neoplasia occurs at particular epithelial sites where vulnerable cells such as the reserve or cuboidal cells of the cervical transformation zone are found. Beta papillomavirus infection can also predispose an individual with immune deficiencies to the development of cancers. The host control of HPV infections thus involves local interactions between keratinocytes and the adaptive immune response. Effective immune detection and surveillance limits overt disease, leading to HPV persistence as productive microlesions or in a true latent state.
Keywords: CIN; Epithelial homeostasis; HPV; Infection; Papillomavirus; Wart.
Copyright © 2017. Published by Elsevier Ltd.
Similar articles
-
Human papillomavirus types in cervical dysplasia among young HPV-vaccinated women: Population-based nested case-control study.Int J Cancer. 2020 May 1;146(9):2539-2546. doi: 10.1002/ijc.32848. Epub 2020 Jan 24. Int J Cancer. 2020. PMID: 31868230
-
HPV vaccination for the prevention of cervical intraepithelial neoplasia.N Engl J Med. 2009 Jul 16;361(3):271-8. doi: 10.1056/NEJMct0806938. N Engl J Med. 2009. PMID: 19605832 Review. No abstract available.
-
Human papillomavirus genotype attribution for HPVs 6, 11, 16, 18, 31, 33, 45, 52 and 58 in female anogenital lesions.Eur J Cancer. 2015 Sep;51(13):1732-41. doi: 10.1016/j.ejca.2015.06.001. Epub 2015 Jun 26. Eur J Cancer. 2015. PMID: 26121913
-
Molecular biology of human papillomavirus infection and cervical cancer.Clin Sci (Lond). 2006 May;110(5):525-41. doi: 10.1042/CS20050369. Clin Sci (Lond). 2006. PMID: 16597322 Review.
-
[What should be known for the introduction of an HPV vaccine?].Presse Med. 2008 Oct;37(10):1377-90. doi: 10.1016/j.lpm.2008.04.008. Epub 2008 Sep 10. Presse Med. 2008. PMID: 18786806 Review. French.
Cited by
-
Novel computational and drug design strategies for inhibition of human papillomavirus-associated cervical cancer and DNA polymerase theta receptor by Apigenin derivatives.Sci Rep. 2023 Oct 2;13(1):16565. doi: 10.1038/s41598-023-43175-x. Sci Rep. 2023. PMID: 37783745 Free PMC article.
-
Human Papillomavirus and Anal Cancer: Prevalence, Genotype Distribution, and Prognosis Aspects from Midwestern Region of Brazil.J Oncol. 2019 Sep 18;2019:6018269. doi: 10.1155/2019/6018269. eCollection 2019. J Oncol. 2019. PMID: 31641354 Free PMC article.
-
APOBEC3A/B Polymorphism Is Not Associated with Human Papillomavirus Infection and Cervical Carcinogenesis.Pathogens. 2023 Apr 23;12(5):636. doi: 10.3390/pathogens12050636. Pathogens. 2023. PMID: 37242306 Free PMC article.
-
Epidemiology, Molecular Pathogenesis, Immuno-Pathogenesis, Immune Escape Mechanisms and Vaccine Evaluation for HPV-Associated Carcinogenesis.Pathogens. 2023 Nov 23;12(12):1380. doi: 10.3390/pathogens12121380. Pathogens. 2023. PMID: 38133265 Free PMC article. Review.
-
Detection of Equus Caballus Papillomavirus Type-2 in Asymptomatic Italian Horses.Viruses. 2022 Jul 31;14(8):1696. doi: 10.3390/v14081696. Viruses. 2022. PMID: 36016317 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
